Retrospective Study of COVID-19 Vaccines in Patients Undergoing Immunotherapy for Cancer.

Summary

The investigators wish to set up a pharmaco-epidemiological cohort within the Hospital Territorial Groups of the Cévennes-Gard Camargue, East-Hérault and Haute-Garonne and West Tarn on a specific population, patients undergoing immunotherapy for cancer, as currently there is no data available under "real life" conditions following anti-COVID vaccination19. The hypothesis is that patients undergoing immunotherapy will not develop more vaccine-related adverse events than those observed in the efficacy and safety validation studies of the BNT162b2 mRNA Covid-19, mRNA-1273 SARS CoV-2, Oxford/AstraZeneca and Ad26COV2.S, JMJ Vaccine or J \& J COVID-19 Vaccine.

Conditions

• Cancer
• Immunotherapy

Sponsors & Collaborators

• University Hospital, Montpellier

  collaborator OTHER

• Institut du Cancer de Montpellier - Val d'Aurelle

  collaborator OTHER

• Centre Hospitalier de Bagnols-sur-Cèze

  collaborator UNKNOWN

• Centre Hospitalier du Bassin de Thau

  collaborator UNKNOWN

• University Hospital, Toulouse

  collaborator OTHER

• Centre Hospitalier de Cahors

  collaborator UNKNOWN

• Centre Hospitalier d'Auch

  collaborator UNKNOWN

• Centre Hospitalier Intercommunal de Castres

  collaborator UNKNOWN

• Centre Hospitalier d'Albi

  collaborator UNKNOWN

• Clinique Claude Bernard, Albi

  collaborator UNKNOWN

• Centre Hospitalier de Bigorre - Tarbes

  collaborator UNKNOWN

• Clinique La Croix du Sud Quint-Fonsegrives

  collaborator UNKNOWN

• Clinique Les Cèdres Cornebarrieu

  collaborator UNKNOWN

• Centre Hospitalier Ales

  collaborator UNKNOWN

• CENTRE HOSPITALIER COMMINGES PYRENEES

  collaborator UNKNOWN

• Centre Hospitalier Universitaire de Nīmes

  lead OTHER

Principal Investigators

• Nadine HOUEDE, Professeur · Centre Hospitalier Universitaire de Nīmes

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2021-10-19

Primary Completion

2024-01-01

Completion

2024-06-01

Countries

• France

Study Locations